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Summary
Introduction 
Deep brain stimulation (DBS) has been proposed for the treat-
ment of severe and refractory major depressive disorder, includ-
ing DBS of Broadman’s area 25 (BA 25 subgenual cortex). 
Report
We report DBS of this cerebral region in a patient affected by 
long-lasting disabling and drug-resistant bipolar disorder previ-
ously submitted to electroconvulsive therapy (ECT) and vagal 
nerve stimulation (VNS). 
Results 
After the procedure and at 2.5 years follow-up the patient pre-
sented substantial improvement of depressive
symptoms and maintained a stable drug therapy regimen
Discussion
Our results suggest a possible therapeutic role for BA 25 DBS 
even in patients affected by bipolar disorder previously treated 
by ECT and VNS.
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Introduction
Major depression is the most common psychiatric dis-
order and the fourth most common disabling condition 
worldwide 1; it is nowadays seen as a system-level patho-
logical condition affecting several cerebral functional sub-
circuits, such as cortical, limbic, and subcortical circuits, 
and the system of related molecular and neurotransmitter 
mediators 2 3. Pathogenesis of this disorder is multifacto-
rial, involving genetic, mala-adaptive, and environmental 
factors; the treatment of the disease must thus take into 
account these complex physiopathological features, the 
heterogeneity of depression and its possible clinical evo-
lution and worsening with time. Neuromodulation proce-
dures have been proposed for patients who do not receive 
substantial benefit from conservative treatments, includ-
ing drug therapy and psychotherapy; in particular, several 
and recent lines of evidence point to the role of subgenual 
cortex (Broadman area 25) as target of deep brain stimula-
tion (DBS) in this disease and the theoretical feasibility of 
such modality even for bipolar patients 4 5.
We report the clinical case of a patient with refractory 
bipolar disorder who underwent area 25 DBS after be-
ing previously submitted to vagal nerve stimulation (VNS) 
without clinical benefit. Both procedures were performed 
at our Institute.
Case report
A 46-year-old male patient suffered from depression for 
20 years before the first admittance at our Institute. De-
pressive symptoms developed when he was 22 after a dis-
appointment in love. He started developing decrease of 
self-esteem, sadness and loss of interest in his daily activi-
ties which became progressively pervasive and led the pa-
tient into a complete anhedonic state. He lost his feelings 
for his parents, son and friends. He tried pharmacological 
treatment with several classes of antidepressant medica-
tions (selective serotonin reuptake inhibitors, noradrena-
lin reuptake inhibitors, tricyclic antidepressants, sodium 
valproate, promazine, aripiprazole, benzodiazepines) and 
in different combinations without clinical benefit. Depres-
sive symptoms progressively worsened over time, and the 
patient started to refer suicidal intentions. Maniacal epi-
sodes (lasting about one month) were also present and in-
termingled with depressive episodes, with decreased need 
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Intraoperative macrostimulation was then performed us-
ing several configurations among the four contacts of the 
DBS electrode (St Jude Medical, Inc., St Paul, MA, USA) 
in bipolar mode and in unipolar mode. It did not lead to 
any acute affective, cognitive or behavioural changes. At 
the end of the procedure a CT scan, again merged with 
pre-operative MRI images, confirmed the positioning of 
the electrode within the white matter of subgenual cor-
tex, bilaterally, and excluded surgical complications. The 
patient was again led to the operating room and under-
went positioning of the internal pulse generators (IPGs) 
under general anaesthesia.
After 6 months of chronic stimulation the patient gradu-
ally started to improve, although the search for stimula-
tion parameters considered to be optimal for the clinical 
result were found only after 5 months of trial and error 
attempts (bilaterally: 2.5 mA, 91 microsec as pulse width, 
130 Hz as frequency, unipolar stimulation with the most 
distal contact as cathode).
At 2.5 years-follow-up, the HRSD has decreased from 32 
to 8 (mild depression) (Fig. 2).
Discussion
Up to 20% of patients with major depression are resist-
ant to conservative therapeutic modalities, which include 
for sleep, increased sexual activity, ideas of grandiosity 
and unrestrained expenses with economical ruin).
Psychotherapy in combination with drug therapy was 
equally ineffective. Electroconvulsive therapy (ECT) ad-
ministered on 6 sessions concomitantly with the most 
acute stages of the disease relieved symptoms for only 
few hours.
He was admitted to our Institute in 2006 with Hamilton 
Rating Scale for Depression (HRSD 21 items) score of 32 
(severe depression). Drug therapy at that time consisted 
of carbamazepine 600 mg/day, venlafaxine 150 mg/day 
and mirtazapine 15 mg/day. The last maniac episode oc-
curred 1 year before admittance.
After complete review of clinical history, extensive psy-
chiatric evaluation and informed consent he was submit-
ted to surgical intervention of positioning of VNS system. 
VNS was effective for a limited period (4 months), after 
which he progressively worsened and was unable to per-
form daily activities, including going out for a walk or 
gardening. Ingravescence of symptoms persisted even af-
ter gradual increase of the intensity of stimulation of the 
VNS system to 3.0 mA, and suicidal thoughts became 
increasingly frequent.
We then decided to propose surgical intervention of DBS 
of Broadman area 25.
After informed written consent, surgery was performed in 
January 2008.
DBS was carried on in stereotactic conditions with the 
Leksell headframe (Elekta Inc., Atlanta GA, USA). Com-
puterized tomography (CT) was used to recognize the 
anterior and posterior commissures in the stereotactic 
space, after positioning of the head frame. The stereotac-
tic CT images were then merged with the preoperative 
magnetic resonance images (MR; T1 and fast spin echo 
inversion recovery sequences with double dose of con-
trast-agent) and calculation of the target coordinates was 
performed with the neuronavigation system (Stealth Sta-
tion Treon SofamorDanek, Medtronic Inc. Minneapolis, 
MN, USA). The definitive coordinates of the target (infe-
rior bank of subgenual cortex, bilaterally), along with the 
planned trajectory, were established.
In the operating room, a rigid cannula was inserted 
trough a small hand drilled burr hole (5 mm diameter) 
and through the opened dura mater, bilaterally; the can-
nula was then indwelled till 10 mm above the estimated 
target. A high impedance microelectrode (250 µm tip, 
and impedance 1-1.5 MΩ; FHC Inc., Bowdoinham ME, 
USA) was introduced within the cannula and advanced 
progressively into the cortex and subcortical white mat-
ter. Microrecording tracks were performed with 0.5 mm 
steps until reaching the estimated target, and at this site 
rich multi-unit neuronal activity was confirmed, consist-
ent with penetration of the electrode within a cortical 
structure (area 25 of Broadman) (Fig. 1).
FIgure 1.
Decrease of the score in the Hamilton Rating Scale for Depression 
in our patient. Functionality in the different spheres of his life 
gradually improved, and the patient now spends much more 
time in working and often goes out for a walk. Drug therapy 
has remained stable until the last follow-up. Diminuzione 
del punteggio della Scala di Hamilton per la depressione nel 
nostro paziente. La funzionalità delle diverse sfere delle attività 
della vita quotidiana sono gradualmente migliorate; adesso il 
paziente trascorre molto più tempo nell’attività lavorativa e 
nel tempo libero. La terapia farmacologica è rimasta stabile 
all’ultimo follow-up.
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frequency chronic stimulation of the hypermetabolic area 
allowed control of headache attacks.
Therefore, it was possible to speculate about the efficacy 
of high frequency chronic stimulation of the CG 25 area 
to treat major depression through inhibition of hyperac-
tive neuronal pools.
The first study to report the results of DBS of BA 25 was 
that of Mayberg in 2005 12 in six patients. Selection cri-
teria for surgery were clinical history of major depres-
sive disorder (MDD) for at least one-year duration as 
diagnosed according to the DSM-IV, a minimum score 
of 20 on the 17-item Hamilton Depression Rating Scale 
(HDRS), failure to a minimum of 4 treatment modalities 
(comprising medications, psychotherapy and ECT). Ex-
clusion criteria were: comorbid Axis I disorders, cluster B 
Axis II disorders, suicidal behaviour within the past year 
and concomitant medical condition potentially interfer-
ing with surgery.
Response criteria was defined as a decrease of the HDRS 
score of 50% or more, remission criterion was a score in 
the HDRS of 7 or less; at six months follow-up the benefi-
cial effect was maintained in four out of six patients; one 
responder patient underwent blinded discontinuation of 
the stimulation, with progressive loss of improvement af-
ter 3 weeks from turnoff.
Three years later the same group reported the results of 
BA 25 DBS in 14 additional patients, thus resulting into 
a series of 20 patients  4. At 12 months follow-up, 55% 
of patients were responders and 35% were remitters; the 
maximal improvement of mood was achieved within 3 
months, whereas improvement in the other aspects of 
the depressive disorder (such as anxiety and somatic 
symptoms) required longer times. Interestingly, PET scan 
performed in 8 patients who benefited from stimulation 
revealed a decrease in metabolism in the volumes ad-
jacent to the electrodes, whereas significant changes in 
metabolism were observed in brain areas known to be 
functionally related to BA 25 (for instance, decrease in 
orbito-frontal cortex and medial prefrontal cortex and in-
crease in the lateral prefrontal cortex and in the anterior 
and posterior cingulated gyrus).
Other targets for DBS in the treatment of major depres-
sion have been proposed, including the inferior thalamic 
peduncle (ITP), rostral cingulated cortex, nucleus accum-
bens/ventral striatum (Nacc) and lateral habenula; all 
these potential targets share substantial connections with 
several other cortical and subcortical structures of the lim-
bic circuits thought to play a major role in the pathogen-
esis of this disorder based on metabolic and morphologic 
neuroimaging studies related to clinical observations 13. 
Only three of the proposed targets have been used so far 
(ITP, Nacc and BA 25), with variable results.
In the present case, the patient was highly resistant to 
all conservative treatments attempted and to vagal nerve 
pharmacological treatment (often multimodal, with trial 
and error drug combinations), psychotherapy and elec-
troconvulsive therapy. Given that functional neuroim-
aging is gaining wider acceptance as an important tool 
to understand some aspects of several neurological and 
neuropsychiatric conditions  6, correlating phenomenol-
ogy to dysfunction, it is not surprising that it has recently 
played such a role for major depression.
In fact, Mayberg in 1999 and Seminowicz in 2004 7 8 
pointed out the increased metabolic activity of the sub-
genual cortex with regard to negative affective states 
and its relation to the efficacy of the different treatment 
modalities; metabolic activity of this region correlates 
with responsiveness to serotoninergic, ECT, ablative 
surgery and transcranial magnetic stimulation thera-
pies 9-11.
Similar focal rise of metabolic activity had been previous-
ly detected within the posterior hypothalamus in patients 
with chronic cluster headache. In these patients, the high 
FIgure 2.
Upper left: post operative magnetic resonance of the patient; 
the artefacts due to the presence of the electrodes are visible. 
Upper right: two sagittal slices of the postoperative CT scan 
merged with the preoperative MRI, showing the location of the 
electrodes. Lower: multi-unit neuronal activity recorded at the 
target (cortex of the subgenual gyrus). Sinistra, in alto: Risonanza 
Magnetica encefalica post-operatoria del paziente; sono visibili 
gli artefatti dovuti alla presenza degli elettrodi. Destra, in alto: 
due sezioni sagittali dell’esame TAC encefalo post-operatorio 
fuse con l’esame RM encefalo pre-operatorio, che evidenzia 
la posizione degli elettrodi. In basso: Attività neuronale “Multi-
unit” registrata al target (corteccia subgenuale).
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stimulation, which has been reported to be effective in a 
substantial portion of patients in several studies 14-16. The 
relative safety and efficacy of DBS of BA 25 as report-
ed in the most recent studies convinced us to try such 
a modality for alleviating depressive symptoms in our 
patient, even though the diagnosis was bipolar disorder 
and not unipolar depressive disorder, the latter being the 
most frequent reported indication for DBS to date; our 
results seem encouraging enough to continue exploring 
the possibilities of DBS as adjunctive therapy in carefully 
selected patients in the future.
Future studies correlating neuroimaging and clinical data 
and involving larger groups of carefully selected patients 
are necessary to refine this procedure, from more accu-
rate selection of patients to more precise assessment of 
predictive data. A multidisciplinary approach and regular 
cooperation with psychiatrists is mandatory.
Conclusion
Our positive results with the use of BA 25 DBS suggest a 
possible role for BA 25 DBS even in patients previously 
affected by maniac episodes within the context of a se-
vere depressive syndrome; Finally, this case report sug-
gests that the mechanisms of action of BA 25 chronic 
high frequency stimulation may be different from those 
of ECT and VNS.
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